O009/#786 Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious brca mutation: efficacy and safety from ariel4, a randomized phase 3 study
R. Kristeleit, A. Lisyanskaya, A. Fedenko, M. Dvorkin, A. de Melo, Y. Shparyk, I. Rakhmatullina, I. Bondarenko, N. Colombo, V. Svintsitskiy, L. Biela, M. Nechaeva, F. Raspagliesi, G. Scambia, D. Cibula, R. poka, A. Oaknin, T. Safra, B. Maćkowiak-Matejczyk, L. Ma
{"title":"O009/#786 Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious brca mutation: efficacy and safety from ariel4, a randomized phase 3 study","authors":"R. Kristeleit, A. Lisyanskaya, A. Fedenko, M. Dvorkin, A. de Melo, Y. Shparyk, I. Rakhmatullina, I. Bondarenko, N. Colombo, V. Svintsitskiy, L. Biela, M. Nechaeva, F. Raspagliesi, G. Scambia, D. Cibula, R. poka, A. Oaknin, T. Safra, B. Maćkowiak-Matejczyk, L. Ma","doi":"10.1136/ijgc-2021-igcs.9","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2021-igcs.9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
